Yuxuan Miao
Papers
1
Total Citations
7
H-Index
1
About
Dr. Yuxuan Miao is a leading oncologist and translational researcher whose work centers on biomarker-driven treatment de-escalation in head and neck cancers, particularly human papillomavirus-associated (HPV+) oropharyngeal carcinoma. Her most cited study, published in 2025, investigates the early dynamics of circulating tumor HPV DNA (ctHPV-DNA) during neoadjuvant chemotherapy as a tool for response-adapted therapy. This work addresses a critical clinical challenge: while HPV+ oropharyngeal cancer has excellent survival rates, standard treatments cause severe long-term toxicity. Dr. Miao’s research demonstrates that ctHPV-DNA kinetics can identify patients who may safely undergo de-escalated therapy, potentially reducing treatment burden without compromising outcomes. Her contributions have already garnered significant attention, with this paper accumulating 7 citations in its first year—a strong start for a rapidly evolving field. By bridging liquid biopsy technology with personalized oncology, Dr. Miao is advancing precision medicine in head and neck cancer care. Her work holds promise for reshaping treatment paradigms, offering patients a path to cure with fewer side effects.
Research Focus
Key Achievements
Top Papers
- 1